Advertisement
Am J Health-Syst Pharm
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


American Journal of Health-System Pharmacy, Vol. 64, Issue 10, 1037-1044
Copyright © 2007 by American Society of Health-System Pharmacists
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Seamon, M. J.
Right arrow Articles by Abu-Shraie, N. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Seamon, M. J.
Right arrow Articles by Abu-Shraie, N. A.

Clinical Review

Medical marijuana and the developing role of the pharmacist

Matthew J. Seamon, Jennifer A. Fass, Maria Maniscalco-Feichtl and Nada A. Abu-Shraie

MATTHEW J. SEAMON, PHARM.D., J.D., is Assistant Professor, Pharmacy Practice; JENNIFER A. FASS, PHARM.D., is Drug Information Resident; MARIA MANISCALCO-FEICHTL, PHARM.D., is Assistant Professor, Pharmacy Practice; and NADA A. ABU-SHRAIE, B.SC.PHARM., is Pharm.D. degree candidate, College of Pharmacy, Nova Southeastern University, Fort Lauderdale, FL.

Address correspondence to Dr. Seamon at the College of Pharmacy, Nova Southeastern University, 3200 South University Drive, Fort Lauderdale, FL 33328 (mseamon{at}nova.edu).


Purpose. The pharmacology, therapeutic uses, safety, drug–drug interactions, and drug–disease interactions of medical marijuana are reviewed, and the legal issues related to its use and the implications of medical marijuana for the pharmacist are presented.

Summary. Marijuana contains more than 460 active chemicals and over 60 unique cannabinoids. The legal landscape surrounding marijuana is surprisingly complex and unsettled. In the United States, 11 states and several municipalities have legalized medical marijuana. Another state provides legislation that allows patients to claim a defense of medical necessity. Nevertheless, patients using medical marijuana may never interact with a pharmacist. Marijuana is a Schedule I controlled substance and its use is illegal under federal law. Marijuana has a number of purported therapeutic uses with a broad range of supporting evidence. There are five general indications for medical marijuana: (1) severe nausea and vomiting associated with cancer chemotherapy or other causes, (2) weight loss associated with debilitating illnesses, including HIV infection and cancer, (3) spasticity secondary to neurologic diseases, such as multiple sclerosis, (4) pain syndromes, and (5) other uses, such as for glaucoma. Marijuana is associated with adverse psychiatric, cardiovascular, respiratory, and immunologic events. Moreover, marijuana may interact with a number of prescription drugs and concomitant disease states.

Conclusion. Several states have legalized the use of marijuana for chronic and debilitating medication conditions. Pharmacists need to understand the complex legal framework surrounding this issue so that they can protect themselves and better serve their patients.

Index terms: Cannabis; Drug interactions; Laws; Mechanism of action; Toxicity

 



This article has been cited by other articles:


Home page
ASH ANNUAL MEETING ABSTRACTSHome page
V. K. Gotlieb and K. Z. Oo
Marijuana Use and Sickle Cell Disease
Blood (ASH Annual Meeting Abstracts), November 16, 2008; 112(11): 4826 - 4826.
[Abstract]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2007 by the American Society of Health-System Pharmacists.
Advertisement